Allogene Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 12/08/2026 | Mar 2026Filed 12/08/2026 | Sep 2025Filed 06/11/2025 | Jun 2025Filed 12/08/2026 | Mar 2025Filed 12/08/2026 | Sep 2024Filed 06/11/2025 | Jun 2024Filed 06/11/2025 | Mar 2024Filed 06/11/2025 |
|---|---|---|---|---|---|---|---|---|
| $4.6 | — | $0 | $0 | $0 | $0 | $0 | $0 | |
| −$43 | −$43 | −$41 | −$51 | −$60 | −$66 | −$66 | −$65 | |
| −$0.13 | −$0.18 | −$0.19 | −$0.23 | −$0.28 | −$0.32 | −$0.35 | −$0.38 | |
| 329 | 240 | 222 | 219 | 215 | 209 | 190 | 169 |
Trend